Toxicology – Cocaine “Washed-Out” Syndrome

Core Concept

The historical term “cocaine washed-out syndrome” describes marked somnolence or depressed mental status following prolonged or binge cocaine use. In modern terminology, this presentation is better considered part of the acute stimulant crash/withdrawal spectrum rather than a distinct toxicologic syndrome.

A typical stimulant crash consists of exhaustion, hypersomnolence, fatigue, dysphoria, increased appetite, and psychomotor slowing after prolonged stimulant use and sleep deprivation. Current ASAM/AAAP guidance notes that many patients experience approximately 12–24 hours of somnolence and irritability after abrupt reduction or cessation of stimulant use, probably reflecting both catecholaminergic adaptation and accumulated sleep deprivation.

The crucial modern point is:

Profound coma should never automatically be attributed to a cocaine “crash.”

True unresponsiveness requires exclusion of opioid or sedative coexposure, hypoglycemia, hypoxia, hypercapnia, stroke, intracranial hemorrhage, trauma, seizure/postictal state, infection, metabolic abnormalities, and other causes.

Terminology

“Washed-out syndrome” is largely a historical emergency-medicine term and is not commonly used as a formal contemporary diagnostic category. Current guidelines instead describe stimulant withdrawal, whose acute manifestations include hypersomnolence, fatigue, irritability, depression, altered appetite, and psychomotor changes.

Classic cocaine-withdrawal symptoms include dysphoric mood, fatigue, vivid unpleasant dreams, insomnia or hypersomnia, increased appetite, and psychomotor retardation or agitation.

Thus, a better conceptual sequence is:

Repeated cocaine/stimulant use + prolonged wakefulness → stimulant cessation → crash → hypersomnolence + exhaustion + dysphoria

rather than assuming that cocaine directly produces a delayed pharmacologic coma.

Pathophysiology

The older explanation attributed the syndrome simply to catecholamine depletion after repeated cocaine exposure. That concept remains plausible but is incomplete. Modern understanding emphasizes a combination of neuroadaptation to repeated dopaminergic and adrenergic stimulation, changes in reward circuitry, acute withdrawal, and profound sleep debt accumulated during stimulant binges.

ASAM/AAAP specifically notes that early somnolence after stimulant cessation is likely related to both catecholamine depletion and sleep deprivation.

The depressed mental state is therefore often physiologically different from the respiratory and CNS depression produced by opioids, benzodiazepines, or barbiturates.

Typical Time Course

After cessation of a binge, many patients enter an early “crash” characterized by overwhelming tiredness and increased sleep. Current guidance describes 12–24 hours of prominent somnolence and irritability in many patients, although the broader withdrawal syndrome can continue for days.

Subsequent symptoms may include depression, anxiety, insomnia, paranoia, and other psychiatric complaints that can persist for weeks to months in some patients. Sleep may initially increase and later become disrupted.

The older statement that mental status should always normalize within several hours or at most 24 hours is therefore too rigid. Profound coma lasting many hours, however, remains atypical and should trigger renewed diagnostic evaluation.

Clinical Features

The most typical patient is profoundly tired after repeated stimulant use and may sleep for prolonged periods. Mental status may range from lethargy to marked somnolence, but the patient should generally maintain stable ventilation, oxygenation, and hemodynamics unless another complication or coexposure exists.

Vital signs may be normal or may show residual effects of recent stimulant use, such as mild tachycardia or hypertension. Later withdrawal can occasionally be associated with relative bradycardia. Pupils are not reliably diagnostic and may be normal or mid-position.

There should be no persistent focal neurologic deficit attributable simply to stimulant withdrawal. Hemiparesis, aphasia, gaze deviation, severe headache, meningismus, or asymmetric examination findings require evaluation for an alternative neurologic diagnosis.

Why Deep Coma Is a Red Flag

Contemporary stimulant-withdrawal guidance describes somnolence, not unexplained deep coma, as the characteristic acute neurologic finding.

Therefore, a patient who cannot be awakened, does not protect the airway, has significant hypoventilation, or has a Glasgow Coma Scale markedly below normal should not simply be labeled “washed out.”

The differential should remain broad until serious causes have been excluded.

Opioid Coexposure – Major Modern Pitfall

This is perhaps the most important change from the original chapter.

Modern illicit cocaine is often used with or contaminated by other substances, particularly illegally manufactured fentanyl and other opioids. CDC notes that polysubstance exposure involving cocaine and opioids is common, and in 2021 approximately 78.6% of U.S. cocaine-involved overdose deaths also involved an opioid.

Therefore:

Cocaine history + coma or respiratory depression ≠ cocaine crash until opioid toxicity has been considered.

Findings such as bradypnea, apnea, marked miosis, low oxygen saturation, or rising CO₂ should prompt immediate treatment as possible opioid poisoning.

Naloxone

Naloxone does not reverse cocaine withdrawal itself. However, because opioid coexposure is common and may be unintentional:

Give naloxone promptly when opioid toxicity cannot be excluded and respiratory depression is present.

Naloxone is safe and effective for opioid overdose, including fentanyl, but it will not reverse isolated cocaine effects.

Airway support and ventilation should never be delayed while waiting to see whether naloxone works.

Other Important Differential Diagnoses

Other toxicologic causes of depressed consciousness include opioids, alcohol, benzodiazepines, barbiturates, GHB, clonidine, antipsychotics, sedating anticonvulsants, baclofen, and mixed drug overdose.

Medical causes include hypoglycemia, hypoxia, hypercapnia, severe electrolyte abnormalities, renal or hepatic failure, sepsis, meningitis or encephalitis, hypothyroidism, adrenal crisis, stroke, intracranial hemorrhage, head trauma, and postictal states.

Cocaine itself can cause ischemic stroke, intracranial hemorrhage, seizures, myocardial infarction, and hyperthermic multiorgan injury, so a recent cocaine binge does not make these alternative diagnoses less likely.

Cardiac Disease Can Be Hidden by Somnolence

An important historical case described myocardial infarction in a patient initially considered to have cocaine “washed-out syndrome.” Her marked hypersomnolence made assessment of ongoing chest pain difficult.

This remains clinically important. A sleepy patient following a cocaine binge can still have:

Acute coronary syndrome, myocarditis, dysrhythmia, or other cardiovascular injury.

Do not allow a benign-appearing sleeping patient to obscure evidence of serious cocaine-associated disease.

Initial Assessment

The first priorities are airway, breathing, circulation, bedside glucose, temperature, and neurologic examination.

Assess respiratory rate and depth rather than relying solely on oxygen saturation. A patient receiving supplemental oxygen can remain well saturated while developing severe hypercapnia. Capnography is useful when ventilation is uncertain.

Examine for trauma, injection marks, focal neurologic findings, meningismus, hyperthermia, muscle rigidity, and evidence of prolonged immobilization.

Laboratory Evaluation

Testing should be guided by the presentation rather than performed automatically in every mildly sleepy patient. Current ASAM/AAAP guidance recommends symptom-directed testing and identifies CBC, metabolic testing, liver tests, CK/lactate when muscle injury or acidosis is suspected, and cardiac biomarkers when myocardial injury is a concern.

At minimum, significant unexplained depressed consciousness generally warrants bedside glucose, electrolytes, renal function, and an ECG. Additional testing may include liver enzymes, CK, lactate, blood gas, troponin, CBC, urinalysis, and pregnancy testing according to the clinical setting.

In an intentional or uncertain overdose, acetaminophen and salicylate concentrations remain appropriate when occult coingestion is possible.

Blood Gas and Capnography

The old recommendation for routine arterial blood gas analysis in every case is unnecessary. A venous or arterial blood gas is useful when there is:

Hypoventilation, unexplained acidosis, significant hypoxemia, severe systemic illness, or uncertain respiratory status.

Capnography is particularly valuable when respiratory depression from a possible opioid or sedative coexposure is suspected.

Routine methemoglobin measurement is unnecessary unless the clinical presentation specifically suggests methemoglobinemia.

Urine Drug Screening

A positive cocaine urine test generally reflects detection of the metabolite benzoylecgonine and proves only recent exposure. It does not show that cocaine is responsible for the patient’s current coma.

Similarly, standard opioid immunoassays may fail to detect fentanyl, depending on the assay used. Therefore a negative routine “opiate” screen must not be used to rule out fentanyl exposure.

Clinical treatment—including naloxone when appropriate—should not wait for toxicology results.

Neuroimaging

Head CT is indicated when there is concern for:

Head trauma, focal neurologic deficit, severe sudden headache, persistent unexplained coma, intracranial hemorrhage, or stroke.

Cocaine is itself a risk factor for cerebrovascular disease, so clinicians should maintain a low threshold for neuroimaging when the neurologic examination is abnormal.

Routine CT is not required for a patient with a classic, improving stimulant crash and normal neurologic examination.

Lumbar Puncture

Lumbar puncture is not routine for stimulant withdrawal. It should be performed only when there is a specific concern for meningitis, encephalitis, subarachnoid hemorrhage not adequately evaluated by imaging, or another appropriate neurologic indication.

The old approach of automatically obtaining CT, lumbar puncture, and cultures for every deeply sleepy cocaine user is unnecessarily broad; evaluation should be guided by the history and examination.

Treatment

There is no specific pharmacologic antidote for stimulant withdrawal or the cocaine crash. Current care focuses on maintaining physiologic safety, excluding dangerous alternative diagnoses, providing a calm environment, allowing restorative sleep, hydration and nutrition, and treating specific symptoms. ASAM/AAAP states that the modern standard of care for stimulant withdrawal is symptom relief and risk reduction, with environmental and behavioral measures forming an important component.

Airway and Ventilation

A genuinely somnolent withdrawal patient should ordinarily continue to breathe adequately. If ventilation or airway protection is impaired:

Support the airway rather than attributing respiratory failure to “washout.”

Provide oxygen for hypoxemia and bag-mask ventilation when needed. Intubate for persistent apnea, inadequate ventilation, inability to protect the airway, or other standard indications.

At the same time, give naloxone when opioid coexposure is plausible.

Fluids and Nutrition

Many patients have eaten, slept, and hydrated poorly during a stimulant binge. Oral fluids and nutrition are appropriate once the patient is awake and can swallow safely. IV isotonic fluid is appropriate for clinically significant dehydration or associated rhabdomyolysis.

There is no benefit to routine forced diuresis.

Stimulant Withdrawal Medication

No medication is established as a specific treatment for the acute cocaine crash. ASAM/AAAP notes that pharmacotherapies studied for general stimulant withdrawal have limited and generally low-quality evidence.

Medication should therefore target specific clinically significant problems such as persistent depression, psychosis, agitation, or insomnia rather than attempting to “reverse” withdrawal pharmacologically.

Stimulants should not simply be administered to awaken a sleeping patient who has not yet been adequately evaluated.

Psychiatric Symptoms

Withdrawal may include depressed mood, anxiety, irritability, paranoia, and sleep disturbance, and some symptoms can persist for weeks or months.

Patients presenting after stimulant intoxication or withdrawal should be assessed for suicide and self-harm risk. ASAM/AAAP specifically recommends routine assessment of suicidality because people using stimulants have an elevated risk of self-harm.

This is particularly important during the crash when euphoria abruptly gives way to exhaustion, dysphoria, anhedonia, and depression.

Gastrointestinal Decontamination

GI decontamination has no role in the ordinary cocaine “washed-out” syndrome.

The syndrome follows cessation after a binge; there is generally no relevant drug remaining in the stomach that can be removed.

Therefore:

Do not induce vomiting. Do not perform gastric lavage. Do not routinely administer activated charcoal.

Activated charcoal would only be considered if there were a separate, recent, clinically significant oral ingestion for which charcoal is otherwise indicated and the airway is intact or protected.

The old recommendation to administer charcoal merely because a patient presents after cocaine binge use should not be carried forward.

Enhanced Elimination

There is no role for:

Hemodialysis, hemoperfusion, urinary alkalinization, or forced diuresis

for stimulant withdrawal or cocaine elimination.

Management remains supportive.

Prolonged Immobilization

A very somnolent patient may remain in one position for many hours and can develop pressure injury, peripheral nerve compression, or compartment syndrome.

Patients with prolonged unresponsiveness should be examined for:

Limb swelling, tense compartments, severe pain when awake, pressure injuries, and rhabdomyolysis.

Check CK, potassium, and renal function when prolonged immobilization is substantial.

Monitoring

Patients with significant depressed consciousness should have serial assessment of:

Mental status, respiratory rate, oxygenation, ventilation, blood pressure, pulse, temperature, and glucose.

Continuous cardiac monitoring is appropriate when there is:

• Significant altered consciousness
• Chest pain
• Dysrhythmia
• Severe recent cocaine toxicity
• Important coingestion

Monitoring can be reduced once a benign stimulant crash has been established and the patient is clearly recovering.

Admission

The old recommendation that every patient must be admitted is unnecessarily rigid.

Patients with genuine coma, airway compromise, respiratory depression, persistent unexplained altered consciousness, significant cardiovascular abnormalities, serious metabolic abnormalities, stroke/trauma concerns, rhabdomyolysis, or significant coingestion require admission and sometimes ICU care.

A patient with uncomplicated stimulant withdrawal who is sleepy but readily arousable, maintains normal ventilation and hemodynamics, has no concerning alternative diagnosis, and progressively improves may be managed in an appropriate observation setting without mandatory inpatient admission.

Discharge

Discharge is appropriate when the patient is awake enough to function safely, has returned toward neurologic baseline, has stable vital signs and adequate ventilation, can maintain hydration, and has no untreated acute medical complication.

Before discharge, evaluate psychiatric status, particularly depression and suicidality. Persistent severe depression, psychosis, suicidal thoughts, or inability to care for oneself requires further mental-health assessment rather than simple discharge after waking.

Stimulant Use Disorder Treatment

The emergency visit should also be used to identify stimulant use disorder and offer treatment rather than simply allowing the patient to “sleep it off.”

ASAM/AAAP identifies contingency management as the behavioral intervention with the strongest evidence for stimulant use disorder and describes it as the current standard of care, often combined with approaches such as cognitive behavioral therapy or community reinforcement.

There is no single FDA-approved medication specifically for cocaine use disorder, although specialist-directed off-label pharmacotherapies may be considered in selected patients.

Prognosis

Uncomplicated stimulant crash generally has a good prognosis. Prominent sleepiness often improves over approximately 12–24 hours, although fatigue, depression, anxiety, craving, sleep disturbance, and other withdrawal symptoms may continue much longer.

Persistent deep coma or failure to improve should not simply be attributed to cocaine withdrawal. The differential diagnosis must be reopened and additional toxicologic, neurologic, infectious, or metabolic investigation performed.

Important Pitfalls

The most important pitfall is using “washed-out syndrome” as a premature explanation for coma. Modern stimulant withdrawal commonly produces hypersomnolence, but profound unresponsiveness should remain a diagnosis of exclusion.

Another major error is failing to consider fentanyl or another opioid in a patient believed to have used only cocaine. Modern polysubstance exposure is common, and opioid-associated respiratory depression requires naloxone and ventilatory support.

A positive cocaine urine test should not end the diagnostic investigation. Cocaine metabolites remain detectable beyond the period of intoxication and can coexist with stroke, infection, metabolic disease, trauma, or another overdose.

Do not assume that normal vital signs exclude serious disease. A sleeping post-binge patient may still have occult myocardial infarction, as demonstrated in historical cases of so-called washed-out syndrome.

Routine activated charcoal, gastric lavage, lumbar puncture, and broad laboratory testing are not automatically indicated simply because cocaine withdrawal is suspected. Testing and interventions should be guided by the clinical presentation.

Finally, do not overlook depression and suicide risk during the crash and withdrawal period. Modern stimulant guidelines explicitly recommend assessment for suicidality during intoxication and withdrawal.

High-Yield Toxicology Pearls

“Cocaine washed-out syndrome” is best viewed today as an acute stimulant crash/withdrawal state rather than a distinct poisoning syndrome. The expected picture is exhaustion, hypersomnolence, fatigue, dysphoria, increased appetite, and psychomotor slowing after prolonged cocaine or other stimulant use.

Many patients have marked sleepiness for approximately 12–24 hours, reflecting stimulant withdrawal and accumulated sleep deprivation. However, deep coma is not a diagnosis to accept casually.

In a cocaine user with profound depressed consciousness, always consider opioid/fentanyl coexposure, alcohol or sedatives, hypoglycemia, hypoxia/hypercapnia, stroke or intracranial hemorrhage, head injury, seizure/postictal state, infection, and metabolic disease.

Respiratory depression should prompt immediate airway assessment and naloxone when opioid exposure cannot be excluded. A positive cocaine urine screen proves recent exposure but does not prove that cocaine caused the coma.

There is no antidote for the stimulant crash and no role for routine activated charcoal, gastric lavage, dialysis, or forced elimination. Treatment is supportive: protect the airway when necessary, provide hydration and nutrition, allow restorative sleep, monitor for complications, and investigate atypical findings.

Patients should also be screened for depression, suicidality, and stimulant use disorder. Persistent psychiatric symptoms require treatment, and contingency management currently has the strongest evidence among behavioral treatments for stimulant use disorder.

The single most important modern pearl is:

Cocaine binge + sleepiness may be withdrawal; cocaine binge + coma must be proven safe before calling it “washed out.”